SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTriple Point Ve Regulatory News (TPV)

Share Price Information for Triple Point Ve (TPV)

Share Price is delayed by 15 minutes
Get Live Data
86.00    0.00 (0.00%)
Bid:
84.50
Ask:
87.50
Spread: 3.00 (3.55%)
Market Cap: £114.69m
TPV Live PriceLast checked at - London Stock Exchange

Intraday Triple Point Ve Share Chart

Interim Management Statement

17 Jan 2013 09:30

RNS Number : 7695V
TP70 VCT Plc
17 January 2013
 



 

 

 

 

 

TP70 VCT plc

 

16 January 2013

 

Interim Management Statement for the quarter ended 30 November 2012

 

TP70 VCT plc ("the Company") submits its Interim Management Statement for the period ended 30 November 2012. This constitutes the Company's second Interim Management Statement for the financial year ending 28 February 2013, as required by the UK Listing Authority's Disclosure and Transparency Rule 4.3.

 

Net assets at 30 November 2012 comprised:

 

30 November 2012

31 August 2012

29 February 2012

Unaudited

Unaudited

Audited

£'000

% investments

£'000

% investments

£'000

% investments

VCT qualifying unquoted investments

4,827

90.4

4,827

74.4

17,636

77.3

 

Non VCT qualifying investments:

Unquoted investments

-

-

431

6.6

-

-

Money Market

-

-

500

7.7

-

-

GAM Diversity

-

-

-

-

3,289

14.4

Cash and cash equivalents

514

9.6

734

11.3

1,880

8.3

Total Investments

5,341

100.0

6,492

100.0

22,805

100.0

Other assets & liabilities

(239)

(260)

(101)

Net assets

5,102

6,232

22,704

Net asset value per share

15.95p

19.48p

70.97p

Realisation of Investments

The Board is pleased to announce that the Company's exit strategy is well advanced. The Company realised £12.8 million of qualifying investments since the year ended 29 February 2012 and is in advanced negotiations to conclude the realisation of its remaining investments. Its exposure to GAM Diversity held through a note executed with Julius Baer was closed and proceeds of £3.3 million were also received during the period since the year end.

 

 

Distributions

As a result of the realisations described above a dividend of 52.4p per share was paid to shareholders on 25 May 2012 and 3.59p per share was paid on 21 September 2012, which taken together with the period end net asset value of 15.95p is equal to 71.94p per share, an increase of 0.97p over the position at 29 February 2012.

 

On 21 December the Board announced payment of a further dividend of 4.38p to be paid on 18 January 2013. The expectation is that a 4th more substantial dividend will be announced before the end of January.

 

 

Remaining Investments

It is expected that the realisation proceeds from the remaining investments will be not less than book value.

 

The remaining investments can be analysed as follows:

 

Electricity Generation

Industry Sector

Cinema Digitisation

Solar PV

Anaerobic Digestion

Total Qualifying Investments

Qualifying Investments £'000

176

3,317

1,334

4,827

Qualifying Investments %

3.65%

68.72%

27.63%

100.00%

 

 

Material Events and Transactions

During the period no shares were issued and no shares were purchased by the Company for cancellation.

 

 

Further Information

For further information, please contact Claire Ainsworth or Chris Tottle at Triple Point Investment Management LLP on 0207 201 8989.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSBRMLTMBTBMPJ
Date   Source Headline
7th Dec 20234:09 pmRNSTransaction in Own Shares
1st Dec 202311:41 amRNSTotal Voting Rights
30th Nov 202312:00 pmRNSIssue of Equity and Total Voting Rights
29th Nov 20237:00 amRNSVenture Share Class Net Asset Value
3rd Nov 20233:39 pmRNSTransaction in Own Shares
1st Nov 20239:00 amRNSTotal Voting Rights
27th Oct 202310:57 amRNSIssue of Equity and Total Voting Rights
24th Oct 20237:00 amRNSResults for the six months ended 31 August 2023
2nd Oct 202311:30 amRNSTotal Voting Rights
22nd Sep 202311:52 amRNSPublication of Prospectus
4th Sep 20237:00 amRNSIssue of Equity and Total Voting Rights
1st Sep 20237:00 amRNSTotal Voting Rights
4th Aug 20233:18 pmRNSTransaction in Own Shares
1st Aug 20238:00 amRNSTotal Voting Rights
1st Aug 20237:00 amRNSIntention to Launch an Offer for Subscription
28th Jul 20234:30 pmRNSIssue Of Equity and Total Voting Rights
19th Nov 201311:08 amRNSCancellation of Listing
18th Nov 20133:54 pmRNSCancellation of Listing
18th Nov 201310:47 amRNSResults of General Meeting-Cancellation of Listing
22nd Oct 20132:20 pmRNSProposed De-listing and Notice of General Meeting
18th Oct 20133:28 pmRNSHalf Yearly Report
10th Jul 201310:47 amRNSInterim Management Statement
27th Jun 201311:07 amRNSFinal Results
31st Jan 20132:18 pmRNSDividend Declaration
17th Jan 20139:30 amRNSInterim Management Statement
21st Dec 20124:07 pmRNSDividend Declaration
19th Oct 201212:04 pmRNSHalf Yearly Report
30th Aug 20124:22 pmRNSDividend Declaration
6th Jul 20124:19 pmRNSInterim Management Statement
26th Jun 20125:17 pmRNSFinal Results
9th May 20122:51 pmRNSDividend Declaration
27th Apr 201212:15 pmRNSCompany Update
16th Jan 20124:40 pmRNSInterim Management Statement
7th Oct 201110:35 amRNSHalf Yearly Report
29th Sep 20112:44 pmRNSDirectorate Change
12th Jul 201111:39 amRNSInterim Management Statement
17th May 201112:49 pmRNSFinal Results
7th Feb 20113:18 pmRNSTransaction in Own Shares
14th Jan 20114:42 pmRNSInterim Management Statement
22nd Oct 20102:16 pmRNSHalf Yearly Report
22nd Oct 20102:16 pmRNSHalf Yearly Report
20th Jul 20102:59 pmRNSInterim Management Statement
29th Jun 201011:34 amRNSFinal Results - Replacement
22nd Jun 20105:51 pmRNSFinal Results
11th Jan 201010:23 amRNSInterim Management Statement
16th Oct 200910:39 amRNSHalf Yearly Report
20th Jul 20094:20 pmRNSInterim Management Statement
30th Jun 20096:09 pmRNSFinal Results
16th Jan 20093:40 pmRNSInterim Management Statement
28th Nov 20081:31 pmRNSInterim Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.